Joshua Allen
Chief Tech/Sci/R&D Officer at CHIMERIX, INC.
Profile
Joshua E.
Allen is currently the Chief Technology Officer at Chimerix, Inc. Prior to his current position, he served as the Chief Scientific Officer at Oncoceutics, Inc. from 2003 to 2021.
Dr. Allen holds a doctorate degree from the University of Pennsylvania.
Joshua Allen active positions
| Companies | Position | Start |
|---|---|---|
| CHIMERIX, INC. | Chief Tech/Sci/R&D Officer | 31/12/2020 |
Former positions of Joshua Allen
| Companies | Position | End |
|---|---|---|
Oncoceutics, Inc.
 Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | 31/12/2020 |
Training of Joshua Allen
| University of Pennsylvania | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Oncoceutics, Inc.
Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Joshua Allen
